基因决定代谢物对慢性病的因果关系:双样本孟德尔随机化研究在中
Zekai Zhang1, Beibei Cao2, Qiutong Wu1
1Second College of Clinical Medicine, Nanjing Medical University, Nanjing, China.
Metabolic syndrome and related disorders
|May 14, 2024
概括
这项研究确定N-乙诺尼丁是增加慢性病 (CKD) 风险的代谢物. 这一发现表明N-乙诺尼丁和相关的代谢途径可能是CKD的治疗点.
科学领域:
- 代谢学和遗传流行病学
- 脏生理学和疾病机制
背景情况:
- 慢性病 (CKD) 与代谢障碍有关,但代谢物和CKD之间的因果关系尚不清楚.
- 了解代谢物因果关系对于阐明CKD病原体和确定治疗点至关重要.
研究的目的:
- 利用孟德尔随机化研究486种血液代谢物在慢性病 (CKD) 的发展中的潜在因果作用.
- 确定与CKD风险和进展相关的特定代谢物和代谢途径.
主要方法:
- 使用全基因组关联研究 (GWAS) 数据对486种代谢物和CKD进行双样本孟德尔随机化 (MR) 分析.
- 主要分析采用逆方差加权 (IVW) 方法,MR-Egger和加权中位数作为补充方法.
- 反向MR,链接不平衡得分回归和局部化分析被用于进一步验证和药物标探索 (N-乙诺尼丁).
主要成果:
- N-乙诺尼丁被确定为一种代谢物,显著增加了对估计膜过率 (eGFR) 降低和CKD的敏感性.
- "甘氨酸和二糖氨酸代谢"和"甘氨酸,氨酸和三氨酸代谢"途径与CKD发展有显著的关联.
- 局部化分析证实了N-乙诺尼丁与CKD和eGFR之间存在强烈的遗传联系,IVW-MR显示了与CKD的显著正相关性 (OR=1.43) 和与eGFR的负相关性 (b=-0.04).
结论:
- N-乙诺尼丁因果影响CKD风险和eGFR,突出其在疾病发病过程中的作用.
- 已确定的代谢途径和N-乙诺尼丁代表了管理和治疗慢性病的潜在治疗点.
- 这项研究为特定代谢物和CKD之间的因果关系提供了强有力的证据,促进了我们对代谢对病贡献的理解.
相关概念视频
Factors Affecting Renal Clearance: Renal Impairment
90
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
90
Nonlinear Pharmacokinetics: Causes of Nonlinearity
173
Nonlinearity in drug pharmacokinetics is caused by various factors influencing how a drug is absorbed, distributed, metabolized, and excreted. Understanding these nonlinear processes is crucial for predicting drug behavior in the body and optimizing drug dosing regimens.
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
173


